RxDoctor Payments Data

Jonathan Parish, MD

Neurological Surgery · Charlotte, NCNPI 1811382112

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (27.0%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Penumbra, Inc. at 30.1% of the total. 2025 is the largest year on record at $17,955, more than ten times the $1,249 reported in 2019.

$42,044in general payments, 2019–2025

Across 269 payments — averaging $156.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$13K
  • Spine Wave, Inc.$8K
  • Medtronic$5K
  • Globus Medical$5K
  • Intrinsic Therapeutics$3K
  • Imperative Care, Inc$3K
  • plus $5K from 22 others
$257,304in research payments, 2019–2025

Across 16 payments — averaging $16,081 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Spineart SA$216K
  • Premia Spine, Ltd.$41K

What the payments were for

  • Consulting fees$11,25027%
  • Speaking & faculty fees$9,60023%
  • Travel & lodging$11,33427%
  • Food & beverage$9,55023%
  • Education$3061%
  • Gifts$40%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,044 in reported general payments places this provider in the 75th percentile of 196 neurological surgery providers in North Carolina.

See all neurological surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$194,294
Medicare patients
200
Services billed
657

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methocarbamol33$447
Gabapentin27$283
Tizanidine Hcl28$245
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$157
Methylprednisolone18$119
Cyclobenzaprine Hcl15$104
ClopidogrelClopidogrel Bisulfate15$62
Meloxicam23$43

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →